Kardigan advances three late-stage cardiovascular trials, reports $660.7M cashAug 11Quarterly updatedanicamtivKardigan
Bayer completes Phase 1 nurandociguat bioavailability study; VERIFICATION trial recruitsJul 23Weekly roundup, 2 itemsBayer